|
HY-145767A-50mg
|
MedChemexpress LLC
|
SN-38-CO-DMEDA (TFA) [CAS 1224601-17-5]
|
|
|
|
|
HY-147271-1mg
|
MedChemexpress LLC
|
Mal-PEG8-Val-Ala-PAB-Exatecan [CAS 2679821-39-5]
|
|
Cancer-programmed cell death
|
|
|
HY-147271-10mg
|
MedChemexpress LLC
|
Mal-PEG8-Val-Ala-PAB-Exatecan [CAS 2679821-39-5]
|
|
Cancer-programmed cell death
|
|
|
HY-147271-5mg
|
MedChemexpress LLC
|
Mal-PEG8-Val-Ala-PAB-Exatecan [CAS 2679821-39-5]
|
|
Cancer-programmed cell death
|
|
|
HY-148127-1mg
|
MedChemexpress LLC
|
TAM558 [CAS 1802499-21-3]
|
|
Cancer-programmed cell death
|
|
|
HY-148127-10mg
|
MedChemexpress LLC
|
TAM558 [CAS 1802499-21-3]
|
|
Cancer-programmed cell death
|
|
|
HY-148127-5mg
|
MedChemexpress LLC
|
TAM558 [CAS 1802499-21-3]
|
|
Cancer-programmed cell death
|
|
|
HY-150233-1mg
|
MedChemexpress LLC
|
Cys-McMMAF [CAS 1160590-05-5]
|
|
Cancer-programmed cell death
|
|
|
HY-150233-10mg
|
MedChemexpress LLC
|
Cys-McMMAF [CAS 1160590-05-5]
|
|
Cancer-programmed cell death
|
|
|
HY-150233-5mg
|
MedChemexpress LLC
|
Cys-McMMAF [CAS 1160590-05-5]
|
|
Cancer-programmed cell death
|
|
|
HY-152963-1mg
|
MedChemexpress LLC
|
Tisotumab vedotin [CAS 1418731-10-8]
|
|
Cancer-programmed cell death
|
|
|
HY-152963-5mg
|
MedChemexpress LLC
|
Tisotumab vedotin [CAS 1418731-10-8]
|
|
Cancer-programmed cell death
|
|
|
HY-153360-1mg
|
MedChemexpress LLC
|
MC-GGFG-AM-(10Me-11F-Camptothecin) [CAS 2873460-70-7]
|
|
Cancer-programmed cell death
|
|
|
HY-153360-10mg
|
MedChemexpress LLC
|
MC-GGFG-AM-(10Me-11F-Camptothecin) [CAS 2873460-70-7]
|
|
Cancer-programmed cell death
|
|
|
HY-153360-5mg
|
MedChemexpress LLC
|
MC-GGFG-AM-(10Me-11F-Camptothecin) [CAS 2873460-70-7]
|
|
Cancer-programmed cell death
|
|
|
HY-15578-10mg
|
MedChemexpress LLC
|
McMMAF [CAS 863971-19-1]
|
|
Cancer-programmed cell death
|
|
|
HY-15578-100mg
|
MedChemexpress LLC
|
McMMAF [CAS 863971-19-1]
|
|
Cancer-programmed cell death
|
|
|
HY-15578-25mg
|
MedChemexpress LLC
|
McMMAF [CAS 863971-19-1]
|
|
Cancer-programmed cell death
|
|
|
HY-15578-5mg
|
MedChemexpress LLC
|
McMMAF [CAS 863971-19-1]
|
|
Cancer-programmed cell death
|
|
|
HY-15578-50mg
|
MedChemexpress LLC
|
McMMAF [CAS 863971-19-1]
|
|
Cancer-programmed cell death
|
|
|
HY-15583-10mg
|
MedChemexpress LLC
|
Auristatin F [CAS 163768-50-1]
|
|
Cancer-programmed cell death
|
|
|
HY-15583-100mg
|
MedChemexpress LLC
|
Auristatin F [CAS 163768-50-1]
|
|
Cancer-programmed cell death
|
|
|
HY-15583-5mg
|
MedChemexpress LLC
|
Auristatin F [CAS 163768-50-1]
|
|
Cancer-programmed cell death
|
|
|
HY-15583-50mg
|
MedChemexpress LLC
|
Auristatin F [CAS 163768-50-1]
|
|
Cancer-programmed cell death
|
|
|
HY-19318-1g
|
MedChemexpress LLC
|
Fmoc-Val-Cit-PAB [CAS 159858-22-7]
|
|
Cancer-programmed cell death
|
|
